ட்ரெண்ட் வூட்ரஃப் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ட்ரெண்ட் வூட்ரஃப். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ட்ரெண்ட் வூட்ரஃப் Today - Breaking & Trending Today

UniQuest partners with CSL to develop potential new therapy


Share
A potential therapy developed at The University of Queensland may one day save lives by helping patients recover faster from severe trauma, extensive burns and major surgery.
UniQuest, UQ’s technology transfer company, has partnered with global biotechnology company CSL to accelerate the development of a potential treatment for the repair of blood vessels damaged by inflammation.
Dr Coulthard said the technology could benefit critically ill patients with sepsis or acute respiratory distress syndrome, as well as improve patient recovery from heart attack, stroke and organ transplant.
“It may also prevent high-risk patients from developing Systemic Inflammatory Response Syndrome (SIRS), which affects more than half of critically ill patients and contributes to significant mortality and morbidity,” Dr Coulthard said. ....

Trent Woodruff , Perry Bartlett , Mark Coulthard , Nemat Khan , Andrew Boyd , Head Of Global Research Innovation Marthe Dombrain , School Of Biomedical Sciences , Queensland Brain Institute , University Of Queensland , Research Acceleration Initiative , Associate Professor Mark Coulthard , Queensland Children , Professor Trent Woodruff , Biomedical Sciences , Systemic Inflammatory Response Syndrome , Professor Andrew Boyd , Emeritus Professor Perry Bartlett , Queensland Brain , Dean Moss , Global Research Innovation Marthed Ombrain , Acceleration Initiative , ட்ரெண்ட் வூட்ரஃப் , பெர்ரி பார்ட்லெட் , குறி கூல்ட்ஹார்ட் , நேமாத் காந் , ஆண்ட்ரூ பையன் ,

IVERIC bio, Inc. (ISEE) Q1 2021 Earnings Call Transcript


Operator
Good morning, and welcome to the Iveric Bio first-quarter 2021 earnings conference call. [Operator instructions] Please note this call is being recorded. I would now like to turn the conference over to Kathy Galante, senior vice president, investor relations. Please go ahead.
Kathy Galante
Senior Vice President, Investor Relations
Good morning, and welcome to Iveric Bio s conference call. Representing Iveric Bio today are Glenn Sblendorio, chief executive officer; Pravin Dugel, president; David Carroll, chief financial officer; Dhaval Desai, chief development officer; Abraham Scaria, chief scientific officer; and Keith Westby, chief operating officer. I would like to remind you that today, we will be making statements relating to Iveric Bio s future expectations regarding operational, financial and research and development matters, including statements regarding our expectations for patient enrollment and patient retention in GATHER2, our second Phase 3 ....

Nordrhein Westfalen , United States , Tel Aviv , Keith Westby , Stacy Ku Cowen , Iveric Bio , Charles Wykoff , Andreas Lauer , David Nierengarten , Bart Leroy , David Guyer , David Carroll , Trent Woodruff , Pravin Dugel , Stacy Ku , David Nierengarten Wedbush , Arshad Khanani , Kathy Galante , Tiago Fauth , Frank Holz , Peter Kaiser , Mark Pennesi , Glenn Sblendorio , Elias Traboulsi , Abraham Scaria , Dave Carroll ,

Two QIMR Berghofer scientists awarded CSL Research Acceleration Initiative partnerships


Date Time
Two QIMR Berghofer scientists awarded CSL Research Acceleration Initiative partnerships
Two QIMR Berghofer scientists will collaborate with leading global biotechnology company CSL on new immunological targets after being awarded Research Acceleration Initiative partnerships.
The head of the Immunology and Infection Laboratory, Professor Christian Engwerda, and the head of the Molecular Immunology Laboratory, Associate Professor Michelle Wykes, will each receive $500,000 over two years to conduct collaborative research projects with CSL.
As well as the funding, the partnerships also give the researchers access to CSL’s R&D experts.
CSL has awarded four partnerships nationally, with QIMR Berghofer receiving half of those. ....

Christian Engwerda , Trent Woodruff , Mark Coulthard , Marthe Dombrain , Michelle Wykes , Fabienne Mackay , Molecular Immunology Laboratory , Head Of Global Research Innovation , University Of Queensland , Infection Laboratory , Research Acceleration Initiative , University Of Western Australia , Professor Christian Engwerda , Associate Professor Michelle Wykes , Global Research Innovation , Marthed Ombrain , Acceleration Initiative , Professor Wykes , Professor Fabienne Mackay , Professor Livia Hool , Western Australia , Associate Professor Mark Coulthard , Professor Trent Woodruff , Qimr Berghofer , Medical Research , Western Australia ,